about
HIV type 1 Gag as a target for antiviral therapyESCRT-III protein requirements for HIV-1 buddingVirus budding and the ESCRT pathwayThe intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages.Identification and Structural Characterization of the ALIX-Binding Late Domains of Simian Immunodeficiency Virus SIVmac239 and SIVagmTan-1The Phe105 Loop of Alix Bro1 Domain Plays a Key Role in HIV-1 ReleaseMembrane dynamics associated with viral infectionESCRT-independent budding of HIV-1 gag virus-like particles from Saccharomyces cerevisiae spheroplastsPatients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progressionHIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus.Novel approaches to inhibiting HIV-1 replication.Extracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue.The scaffolding protein Dlg1 is a negative regulator of cell-free virus infectivity but not of cell-to-cell HIV-1 transmission in T cellsGalectin-3 promotes HIV-1 budding via association with Alix and Gag p6.Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly.Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding.Membrane buddingAngiomotin functions in HIV-1 assembly and budding.The role of cellular factors in promoting HIV budding.Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation.Super-resolution imaging of ESCRT-proteins at HIV-1 assembly sites.Target silencing of components of the conserved oligomeric Golgi complex impairs HIV-1 replicationRegulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A.A major locus on chromosome 3p22 conferring predisposition to human herpesvirus 8 infectionALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.Identification of the HIV-1 NC binding interface in Alix Bro1 reveals a role for RNA.The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.Viral infection: Moving through complex and dynamic cell-membrane structures.Essential and supporting host cell factors for HIV-1 budding.Dynamics of ESCRT proteins.HIV-1 assembly, budding, and maturation.HIV-1 assembly, release and maturation.Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca(2+) signaling cascade.Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) productionAn LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus.Tsg101 chaperone function revealed by HIV-1 assembly inhibitors.PYRE insertion within HIV-1 subtype C p6-Gag functions as an ALIX-dependent late domain.The KT Jeang Retrovirology prize 2018: Eric Freed.HIV-1 and the macrophage
P2860
Q24614498-3E05B304-5E75-46AB-A338-B733D8A5AB46Q24627115-504131CF-CC6A-4970-BD8C-7B08E3325B96Q26828590-AFD2CDEC-50AF-4D1A-93D5-628772CA98E0Q27304947-DC444DC4-85DB-40A8-99B6-D28335DE13E4Q27665250-73F62C4E-55FD-48C9-9CA5-4DFEECCDE96EQ27672941-6267F7B5-D1C7-4698-9100-5F10DBB58F59Q28069980-BA757B5F-B36B-4CC6-9866-3E12ED3E0C76Q28484533-95ADD053-84B4-45D7-91C6-3C2617D15108Q28542678-C82D415A-78E7-4D0A-ACC8-E4FFCCD00946Q30369511-D129CB3B-5CFF-4177-BF02-E81B35E66C2DQ33624690-E42CD50E-B702-4C60-B378-0F45554FF86DQ33687702-FEEF7668-ABAB-4945-896A-C03857B61E58Q34137493-9C35727A-9B42-4685-9EBC-D80BA8138DAEQ34273352-29BF5BF2-6E88-4BB3-966E-83390C852F9DQ34626162-177579A7-2102-4918-89B9-93ADA0C8A1ECQ34741702-5947C002-1406-46ED-80F5-7ABFAC42C814Q35007633-60587CF1-F86F-47EE-8101-79BEEAD2F782Q35111541-381E9687-F757-4237-A549-39354E7B5D1CQ35113746-EDBDF02D-1FCD-4F36-BFD3-52EAB5D59931Q35173120-72885F84-D6CB-4A65-ACCE-27F0B052DDC7Q35566864-DA213021-6186-41DF-958C-B473B26341CFQ35659568-BDD1008B-A137-45A6-A353-698B0D2F182BQ35826876-A46D47FE-00E3-44A6-BD8F-8A306B28915FQ35969066-6D5E7DA5-AF9A-43E1-9EB7-DAE879F27ED9Q36043157-0F322FD4-72C6-417C-8AD9-F1FC79427AB7Q36363453-5770F2F6-1E22-45E9-9DC4-12E18D606297Q37528045-0BC3B2EA-F77A-43E7-8C5F-1B0CBF7E7159Q37941707-73F8B2A6-4176-41C5-9C80-B5CA0DA8BF0CQ37946431-A3BE4048-F776-4F98-915D-501B2D4956B3Q38016323-BA17B9BF-2523-406D-99C4-1697BCE0909AQ38023864-BE6B8EA9-49D2-44F4-9C6A-B194D60FD51FQ38539565-D859B396-64D0-45C9-898F-177CF42272F9Q38706845-DA066173-7152-4B9E-A444-4383790116C3Q38708714-04EC617A-0A5A-4912-A88F-D880893F6270Q38844095-7E868A22-A78C-410A-B1FA-65F1A1C95DDDQ39714775-0269EA36-6150-4968-B7C5-EF11278BEC1FQ47105110-2E37E684-D5EC-4E4C-88B9-85D5314B88BEQ55259923-6F49C904-12BB-41F5-959D-BDCAE8731FCCQ55517077-C9798F08-B930-4ABA-A077-C4B239EBE536Q55967625-7B4BFE39-CE4A-42B8-862D-E0F35268E5D6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional role of Alix in HIV-1 replication.
@en
Functional role of Alix in HIV-1 replication.
@nl
type
label
Functional role of Alix in HIV-1 replication.
@en
Functional role of Alix in HIV-1 replication.
@nl
prefLabel
Functional role of Alix in HIV-1 replication.
@en
Functional role of Alix in HIV-1 replication.
@nl
P2093
P2860
P1433
P1476
Functional role of Alix in HIV-1 replication.
@en
P2093
Andrew G Stephen
Dimiter G Demirov
Eric O Freed
Ferri Soheilian
Kunio Nagashima
Robert J Fisher
Sherimay D Ablan
Utpal M Munshi
P2860
P304
P356
10.1016/J.VIROL.2009.06.016
P407
P577
2009-09-01T00:00:00Z